We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sanofi Genzyme

News List

KSQ grabs $80M to move T-cell treatment for PD-1 resistance into the clinic fiercebiotech
September 29, 2018
KSQ is focusing on cancer at the moment, but plans to expand its CRISPRomics platform to other areas, such as immunology.
Sanofi Genzyme partners with MSSI to support multiple sclerosis community financialexpress
June 01, 2018
Sanofi Genzyme, the specialty care global business unit of Sanofi, and Multiple Sclerosis Society of India (MSSI) join hands to raise awareness and to provide better treatment solutions for the 130,000 people living with multiple sclerosis (MS) in India.
Sanofi Genzyme Announces Approval of Cerdelga by Health Canada americanpharmaceuticalreview
May 02, 2017
Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc., announced Health Canada has approved Cerdelga (eliglustat capsules) for the treatment of adult patients with Gaucher Disease Type 1.